Protalix BioTherapeutics (PLX) Net Margin (2010 - 2026)
Protalix BioTherapeutics (PLX) reported Net Margin of 18.98% for Q2 2026, up 17.94 percentage points from 1.05% a year earlier but down 35.29 percentage points from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) Net Margin (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Protalix BioTherapeutics' Net Margin came in at 23.50%, up 13.37 percentage points year-over-year; for FY2025, it was -12.52%, down 18.01 percentage points from FY2024.
- Net Margin has a five-year change of -2.15 percentage points (FY2020 to FY2025).
- By year, Net Margin came in at 5.49% in FY2024 (-7.20 pp), 12.69% in FY2023 (+44.03 pp), -31.33% in FY2022 (+40.59 pp) and -71.92% in FY2021 (-61.55 pp).
- Five-year quarterly Net Margin spans a low of -122.60% in Q1 2024 and a high of 55.14% in Q2 2023.
- Year over year, Net Margin gained in six of the last eight quarters, with an average year-over-year change of +30.08 percentage points.
- The high point for year-over-year Net Margin in five years was Q2 2023 (a gain of 116.08 percentage points); the low point was Q4 2025 (a drop of 95.98 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 54.27% (Q1 2026), -60.34% (Q4 2025) and 13.19% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 30.88% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 21.86% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 21.27% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -8.04% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 23.62% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -134.51% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -1.65% |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn | 18.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.98% |
| Mar 31, 2026 | 54.27% |
| Dec 31, 2025 | -60.34% |
| Sep 30, 2025 | 13.19% |
| Jun 30, 2025 | 1.05% |
| Mar 31, 2025 | -35.79% |
| Dec 31, 2024 | 35.65% |
| Sep 30, 2024 | 18.02% |
| Jun 30, 2024 | -16.35% |
| Mar 31, 2024 | -122.60% |
| Dec 31, 2023 | -57.64% |
| Sep 30, 2023 | -17.90% |
| Jun 30, 2023 | 55.14% |
| Mar 31, 2023 | -32.66% |
| Dec 31, 2022 | -43.40% |
| Sep 30, 2022 | -25.15% |
| Jun 30, 2022 | -60.94% |
| Mar 31, 2022 | -14.21% |
| Dec 31, 2021 | -77.99% |
| Sep 30, 2021 | -34.83% |
API Access
Protalix BioTherapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();